Phase I/II Trial of Erlotinib and Temozolomide With Radiation Therapy in the Treatment of Newly Diagnosed Glioblastoma Multiforme: North Central Cancer Treatment Group Study N0177Paul D. Brown, Jan C. Buckner, Wenting Wu et al.|Journal of Clinical Oncology|2008Cited by 275
Phase II Evaluation of Gefitinib in Patients With Newly Diagnosed Grade 4 Astrocytoma: Mayo/North Central Cancer Treatment Group Study N0074Joon H. Uhm, Kurt A. Jaeckle, C. David James et al.|International Journal of Radiation Oncology*Biology*Physics|2010Cited by 186
North Central Cancer Treatment Group Phase I Trial N057K of Everolimus (RAD001) and Temozolomide in Combination With Radiation Therapy in Patients With Newly Diagnosed Glioblastoma MultiformeJann N. Sarkaria, Jan C. Buckner, Steven McGraw et al.|International Journal of Radiation Oncology*Biology*Physics|2010Cited by 89